GOED Publications

The following is a list of peer-reviewed publications co-authored by a GOED employee(s) or commissioned by GOED.

  • Maki KC, Dicklin MR. Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Risk: Glass Half Full or Time to Nail the Coffin Shut? Nutrients. 2018; 10:E864. [Link]
  • De Boer AA, Ismail A, Marshall K, Bannenberg G, Yan KL, Rowe WJ. Examination of marine and vegetable oil oxidation data from a multi-year, third-party database. Food Chem. 2018; 254:249-55. [Link]
  • Maki KC, Palacios OM, Bell M, Toth PP. Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: An updated meta-analysis and review of research gaps. J Clin Lipidol. 2017; 11:1152-60. [Link]
  • Bannenberg G, Mallon C, Edwards H, Yeadon D, Yan K, Johnson H, Ismail A. Omega-3 Long-Chain Polyunsaturated Fatty Acid Content and Oxidation State of Fish Oil Supplements in New Zealand. Sci Rep. 2017; 7:1488. [Link]
  • Rice HB, Bannenberg G, Harwood M, Ismail A. Determining the potential effects of oxidized fish oils in pregnant women requires a more systematic approach. Am J Physiol Regul Integr Comp Physiol. 2017; 312:R263. [Link]
  • Alexander DD, Miller PE, Van Elswyk ME, Kuratko CN, Bylsma LC. A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk. Mayo Clin Proc. 2017; 92:15-29. [Link]
  • Rice HB, Ismail A (2016). Fish Oils in Human Nutrition: History and Current Status In Raatz SK and Bibus DM (eds) Fish and Fish Oil in Health and Disease Prevention. Academic Press, Inc. [Link]
  • Ismail A, Bannenberg G, Rice HB, Schutt E, MacKay D. Oxidation in EPA‐ and DHA‐rich oils: an overview. Lipid Technol. 2016; 28:55-9. [Link]
  • Lupton JR, Blumberg JB, L'Abbe M, LeDoux M, Rice HB, von Schacky C, Yaktine A, Griffiths JC. Nutrient reference value: non-communicable disease endpoints--a conference report.
    Eur J Nutr. 2016; 55 Suppl 1:S1-10. [Link]
  • Rice HB, Bernasconi A, Maki KC, Harris WS, von Schacky C, Calder PC. Conducting omega-3 clinical trials with cardiovascular outcomes: Proceedings of a workshop held at ISSFAL 2014. Prostaglandins Leukot Essent Fatty Acids. 2016; 107:30-42. [Link]
  • Alexander DD, Bassett JK, Weed DL, Barrett EC, Watson H, Harris W. Meta-Analysis of Long-Chain Omega-3 Polyunsaturated Fatty Acids (LCω-3PUFA) and Prostate Cancer. Nutr Cancer. 2015; 67:543-54. [Link]
  • Ismail A, Rice HB. Considerations for incorporating eicosapentaenoic and docosahexaenoic omega-3 fatty acids into the military food supply chain. Mil Med. 2014; 179 Suppl 11:157-61. [Link]
  • Miller PE, Van Elswyk M, Alexander DD. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. Am J Hypertens. 2014; 27:885-96. [Link]
  • Biesalski HK, Erdman JW Jr, Hathcock J, Ellwood K, Beatty S, Johnson E, Marchioli R, Lauritzen L, Rice HB, Shao A, Griffiths JC. Nutrient reference values for bioactives: new approaches needed? A conference report. Eur J Nutr. 2013; 52 Suppl 1:1-9. [Link]
  • Musa-Veloso K, Binns MA, Kocenas A, Chung C, Rice H, Oppedal-Olsen H, Lloyd H, Lemke S. Impact of low v. moderate intakes of long-chain n-3 fatty acids on risk of coronary heart disease. Br J Nutr. 2011; 106:1129-41. [Link]
  • Ismail A. Marine lipids overview: markets, regulation, and the value chain. OCL. 2010; 17:205-8. [Link]
  • Musa-Veloso K, Binns MA, Kocenas AC, Poon T, Elliot JA, Rice H, Oppedal-Olsen H, Lloyd H, Lemke S. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides. Nutr Rev. 2010; 68:155-67. [Link]